Evidence map›Paper›PMID 38743414›Full record

ArticleInvestigative ophthalmology & visual science2024

Retinal Dystrophies Associated With Peripherin-2: Genetic Spectrum and Novel Clinical Observations in 241 Patients.

Rachael C Heath Jeffery, Jennifer A Thompson, Johnny Lo, Enid S Chelva, Sean Armstrong, Jose S Pulido, Rebecca Procopio, Andrea L Vincent, Lorenzo Bianco, Maurizio Battaglia Parodi and 32 more

Abstract readMulticenter Study
In one paragraph

Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Novel HeterozygousInternational journal of molecular sciences · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Bilateral Sector Macular Dystrophy Associated withJournal of clinical medicine · 2025
    Article
  13. Article
  14. The value of genetic testing in pediatric and adult ophthalmology.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2025
    Article
  15. Clearing the AIR: AAmerican journal of ophthalmology case reports · 2025
    Article
  16. Observational
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Rachael C Heath JefferyCentre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.
Jennifer A ThompsonAustralian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Johnny LoSchool of Science, Edith Cowan University, Perth, Western Australia, Australia.
Enid S ChelvaAustralian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Sean ArmstrongCentre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.
Jose S PulidoWills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, United States.
Rebecca ProcopioWills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, United States.
Andrea L VincentDepartment of Ophthalmology, FMHS, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand.
Lorenzo BiancoDepartment of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Maurizio Battaglia ParodiDepartment of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Lucia ZiccardiIRCCS-Fondazione Bietti, Rome, Italy.
Giulio AntonelliIRCCS-Fondazione Bietti, Rome, Italy.
Lucilla BarbanoIRCCS-Fondazione Bietti, Rome, Italy.
João P MarquesOphthalmology Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Clinical and Academic Centre of Coimbra (CACC), Coimbra, Portugal.
Sara GeadaOphthalmology Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Clinical and Academic Centre of Coimbra (CACC), Coimbra, Portugal.
Ana L CarvalhoMedical Genetics Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal.
Wei C TangSingapore National Eye Centre, Singapore, Singapore.
Choi M ChanSingapore National Eye Centre, Singapore, Singapore.
Camiel J F BoonDepartment of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
Jonathan HensmanDepartment of Ophthalmology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands.
Ta-Ching ChenDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Chien-Yu LinDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Pei-Lung ChenDepartment of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Ajoy VincentDepartment of Ophthalmology, Hospital for Sick Children, Toronto, Ontario, Canada.
Anupreet TumberDepartment of Ophthalmology, Hospital for Sick Children, Toronto, Ontario, Canada.
Elise HeonDepartment of Ophthalmology, Hospital for Sick Children, Toronto, Ontario, Canada.
John R GriggSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Robyn V JamiesonSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Elisa E CornishSave Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Benjamin M NashEye Genetics Research Unit, Children's Medical Research Institute, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Shyamanga BorooahUniversity of California San Diego, La Jolla, California.
Lauren N AytonDepartment of Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Alexis Ceecee Britten-JonesDepartment of Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Thomas L EdwardsDepartment of Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Jonathan B RuddleDepartment of Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Abhishek SharmaOphthalmology Department, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Rowan G PorterSouthern Queensland Centre of Excellence, Inala, Australia.
Tina M LameyAustralian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Terri L McLarenCentre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.
Samuel McLenachanCentre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.
Danial RoshandelCentre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.
Fred K ChenCentre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.

Funding

Medical Research Council
6 · The paper itself

Abstract

Purpose: To describe the clinical, electrophysiological and genetic spectrum of inherited retinal diseases associated with variants in the PRPH2 gene. Methods: A total of 241 patients from 168 families across 15 sites in 9 countries with pathogenic or likely pathogenic variants in PRPH2 were included. Records were reviewed for age at symptom onset, visual acuity, full-field ERG, fundus colour photography, fundus autofluorescence (FAF), and SD-OCT. Images were graded into six phenotypes. Statistical analyses were performed to determine genotype-phenotype correlations. Results: The median age at symptom onset was 40 years (range, 4-78 years). FAF phenotypes included normal (5%), butterfly pattern dystrophy, or vitelliform macular dystrophy (11%), central areolar choroidal dystrophy (28%), pseudo-Stargardt pattern dystrophy (41%), and retinitis pigmentosa (25%). Symptom onset was earlier in retinitis pigmentosa as compared with pseudo-Stargardt pattern dystrophy (34 vs 44 years; P = 0.004). The median visual acuity was 0.18 logMAR (interquartile range, 0-0.54 logMAR) and 0.18 logMAR (interquartile range 0-0.42 logMAR) in the right and left eyes, respectively. ERG showed a significantly reduced amplitude across all components (P < 0.001) and a peak time delay in the light-adapted 30-Hz flicker and single-flash b-wave (P < 0.001). Twenty-two variants were novel. The central areolar choroidal dystrophy phenotype was associated with 13 missense variants. The remaining variants showed marked phenotypic variability. Conclusions: We described six distinct FAF phenotypes associated with variants in the PRPH2 gene. One FAF phenotype may have multiple ERG phenotypes, demonstrating a discordance between structure and function. Given the vast spectrum of PRPH2 disease our findings are useful for future clinical trials.

Indexed as

ElectroretinographyPeripherinsPhenotypeRetinal DystrophiesVisual AcuityAdolescentAdultAgedChildChild, PreschoolDNADNA Mutational AnalysisFemaleFluorescein AngiographyGenetic Association StudiesHumansDNAPeripherins

Identifiers

PMID38743414
PMCPMC11098050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.